These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22936067)

  • 1. The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas.
    Hemminger JA; Ewart Toland A; Scharschmidt TJ; Mayerson JL; Kraybill WG; Guttridge DC; Iwenofu OH
    Mod Pathol; 2013 Feb; 26(2):282-8. PubMed ID: 22936067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms.
    Hemminger JA; Iwenofu OH
    Mod Pathol; 2013 Sep; 26(9):1204-10. PubMed ID: 23599152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma.
    Shurell E; Vergara-Lluri ME; Li Y; Crompton JG; Singh A; Bernthal N; Wu H; Eilber FC; Dry SM
    Oncotarget; 2016 Nov; 7(45):72860-72867. PubMed ID: 27655679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.
    Iura K; Kohashi K; Hotokebuchi Y; Ishii T; Maekawa A; Yamada Y; Yamamoto H; Iwamoto Y; Oda Y
    J Pathol Clin Res; 2015 Jul; 1(3):144-59. PubMed ID: 27499900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.
    Hemminger JA; Toland AE; Scharschmidt TJ; Mayerson JL; Guttridge DC; Iwenofu OH
    Mod Pathol; 2014 Sep; 27(9):1238-45. PubMed ID: 24457462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological significance of NY-ESO-1 expression in the diagnosis of myxoid liposarcoma].
    Hei SM; Wei HJ; Chen H; Wang JG
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):225-230. PubMed ID: 30831650
    [No Abstract]   [Full Text] [Related]  

  • 7. NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.
    Pollack SM; Jungbluth AA; Hoch BL; Farrar EA; Bleakley M; Schneider DJ; Loggers ET; Rodler E; Eary JF; Conrad EU; Jones RL; Yee C
    Cancer; 2012 Sep; 118(18):4564-70. PubMed ID: 22359263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NY-ESO-1 (CTAG1B) expression in mesenchymal tumors.
    Endo M; de Graaff MA; Ingram DR; Lim S; Lev DC; Briaire-de Bruijn IH; Somaiah N; Bovée JV; Lazar AJ; Nielsen TO
    Mod Pathol; 2015 Apr; 28(4):587-95. PubMed ID: 25412843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGEA4 expression in bone and soft tissue tumors: its utility as a target for immunotherapy and diagnostic marker combined with NY-ESO-1.
    Iura K; Kohashi K; Ishii T; Maekawa A; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Matsumoto Y; Iwamoto Y; Oda Y
    Virchows Arch; 2017 Sep; 471(3):383-392. PubMed ID: 28744588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ.
    Satie AP; Rajpert-De Meyts E; Spagnoli GC; Henno S; Olivo L; Jacobsen GK; Rioux-Leclercq N; Jégou B; Samson M
    Lab Invest; 2002 Jun; 82(6):775-80. PubMed ID: 12065688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration.
    Theurillat JP; Ingold F; Frei C; Zippelius A; Varga Z; Seifert B; Chen YT; Jäger D; Knuth A; Moch H
    Int J Cancer; 2007 Jun; 120(11):2411-7. PubMed ID: 17294444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy.
    Kohli K; Yao L; Nowicki TS; Zhang S; Black RG; Schroeder BA; Farrar EA; Cao J; Sloan H; Stief D; Cranmer LD; Wagner MJ; Hawkins DS; Pillarisetty VG; Ribas A; Campbell J; Pierce RH; Kim EY; Jones RL; Riddell SR; Yee C; Pollack SM
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.
    Gjerstorff MF; Pøhl M; Olsen KE; Ditzel HJ
    BMC Cancer; 2013 Oct; 13():466. PubMed ID: 24103781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors.
    Sugita Y; Wada H; Fujita S; Nakata T; Sato S; Noguchi Y; Jungbluth AA; Yamaguchi M; Chen YT; Stockert E; Gnjatic S; Williamson B; Scanlan MJ; Ono T; Sakita I; Yasui M; Miyoshi Y; Tamaki Y; Matsuura N; Noguchi S; Old LJ; Nakayama E; Monden M
    Cancer Res; 2004 Mar; 64(6):2199-204. PubMed ID: 15026363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.
    Sato S; Noguchi Y; Wada H; Fujita S; Nakamura S; Tanaka R; Nakada T; Hasegawa K; Nakagawa K; Koizumi F; Ono T; Nouso K; Jungbluth A; Chen YT; Old LJ; Shiratori Y; Nakayama E
    Int J Oncol; 2005 Jan; 26(1):57-63. PubMed ID: 15586225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
    Vaughan HA; Svobodova S; Macgregor D; Sturrock S; Jungbluth AA; Browning J; Davis ID; Parente P; Chen YT; Stockert E; St Clair F; Old LJ; Cebon J
    Clin Cancer Res; 2004 Dec; 10(24):8396-404. PubMed ID: 15623618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipomatous tumors.
    Weiss SW
    Monogr Pathol; 1996; 38():207-39. PubMed ID: 8744279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NY-ESO-1 as a diagnostic and prognostic marker for myxoid liposarcoma.
    Jo U; Roh J; Song MJ; Cho KJ; Kim W; Song JS
    Am J Transl Res; 2022; 14(2):1268-1278. PubMed ID: 35273728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen I is significantly downregulated in patients with myxoid liposarcomas.
    Oike N; Kawashima H; Ogose A; Hatano H; Ariizumi T; Yamagishi T; Murayama Y; Umezu H; Imai C; Hayashi M; Endo N
    Cancer Immunol Immunother; 2021 Dec; 70(12):3489-3499. PubMed ID: 33893830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NY-ESO-1: a promising cancer testis antigen for sarcoma immunotherapy and diagnosis.
    Smith SM; Iwenofu OH
    Chin Clin Oncol; 2018 Aug; 7(4):44. PubMed ID: 30173534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.